Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Reengineering neurotechnology: placing patients first

Neurotechnologies that measure and modulate brain activity have not yet reached widespread clinical relevance. To accelerate translation into patient care, we propose three strategic adjustments in neurotechnology research — to consider the scope, scalability and stakeholders.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Leading causes of disability worldwide.
Fig. 2: 3S principles.

References

  1. Roelfsema, P. R., Denys, D. & Klink, P. C. Trends Cogn. Sci. 22, 598–610 (2018).

    Article  Google Scholar 

  2. Vos, T. et al. Lancet 396, 1204–1222 (2020).

    Article  Google Scholar 

  3. Bouton, C. E. et al. Nature 533, 247–250 (2016).

    Article  Google Scholar 

  4. Willett, F. R., Avansino, D. T., Hochberg, L. R., Henderson, J. M. & Shenoy, K. V. Nature 593, 249–254 (2021).

    Article  Google Scholar 

  5. Price, T. J. et al. Transition to chronic pain: opportunities for novel therapeutics. Nat. Rev. Neurosci. 19, 383–384 (2018).

    Article  Google Scholar 

  6. Wilkinson, S. T., Holtzheimer, P. E., Gao, S., Kirwin, D. S. & Price, R. B. Biol. Psychiatry 85, 454–465 (2019).

    Article  Google Scholar 

  7. Wu, W. et al. Nat. Biotechnol. 38, 439–447 (2020).

    Article  Google Scholar 

  8. Enck, P., Bingel, U., Schedlowski, M. & Rief, W. Nat. Rev. Drug Discov. 12, 191–204 (2013).

    Article  Google Scholar 

  9. Huneke, N. T. M., van der Wee, N., Garner, M. & Baldwin, D. S. Psychol Med. 50, 2317–2323 (2020).

    Article  Google Scholar 

  10. Bolton, D. & Gillett, G. The Biopsychosocial Model of Health and Disease (Cham, 2019).

  11. Paulk, A. C. et al. Nat. Neurosci. 25, 252–263 (2022).

    Article  Google Scholar 

  12. Rashid, B. & Calhoun, V. Hum. Brain Mapp. 41, 3468–3535 (2020).

    Article  Google Scholar 

  13. Polania, R., Nitsche, M. A. & Ruff, C. C. Nat. Neurosci. 21, 174–187 (2018).

    Article  Google Scholar 

  14. Conroy, S. K. & Holtzheimer, P. E. Am. J. Psychiatry 178, 1082–1088 (2021).

    Article  Google Scholar 

  15. Thut, G. et al. Clin. Neurophysiol. 128, 843–857 (2017).

    Article  Google Scholar 

  16. McLennan, S. et al. Nat. Mach. Intell. 2, 488–490 (2020).

    Article  Google Scholar 

Download references

Acknowledgements

The authors are supported by the TUM Innovation Network for Neurotechnology in Mental Health (NEUROTECH).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Markus Ploner or Simon N. Jacob.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Mental Health thanks Surjo Soekadar and Waldemar Karwowski for their contribution to the peer review of this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ploner, M., Buyx, A., Gempt, J. et al. Reengineering neurotechnology: placing patients first. Nat. Mental Health 1, 5–7 (2023). https://doi.org/10.1038/s44220-022-00011-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44220-022-00011-x

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing